4//SEC Filing
Carlson Richard Craig 4
Accession 0001179110-11-007406
CIK 0001222244other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:20 PM ET
Size
11.8 KB
Accession
0001179110-11-007406
Insider Transaction Report
Form 4
Carlson Richard Craig
DirectorCEO
Transactions
- Award
Stock Options
2011-05-03+150,000→ 150,000 totalExercise: $0.97Exp: 2018-05-03→ Common stock, $0.00001 par value (150,000 underlying)
Holdings
- 150,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (150,000 underlying) - 10,000
Stock Options
Exercise: $5.00Exp: 2014-02-01→ Common Stock, $0.00001 par value (10,000 underlying) - 850
Common Stock, $0.00001 par value
- 70,000
Stock options
Exercise: $1.00Exp: 2015-07-11→ Common stock, $0.00001 par value (70,000 underlying) - 100,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (100,000 underlying)
Footnotes (4)
- [F1]The Option shall vest as enumerated: (a) 50,000 shares are vested and currently exercisable; (b) 20,000 shares vest on July 1, 2011.
- [F2]Immediately exercisable.
- [F3]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
- [F4]The options will vest in the amounts indicated below upon achievement of the following objectives within nine months of the Company's receipt of FDA clearance to sell the ProUroScan System in the U.S.:25% vesting - upon recording $500,000 in sales, 15% vesting upon the raising of $5 million in new funding, 30% vesting upon the execution of a corporate partner agreement, 30% vesting upon the filing of three new patent applications.
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001353829
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:20 PM ET
- Size
- 11.8 KB